Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01150968 · ClinicalTrials.gov registry record · NA
An Educational Intervention to Improve Resident Comfort With Communication at the End of Life
A NA study of End of Life Communication, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 166
- Enrollment target
- 1
- Study location
NCT01150968: Completed NA study of End of Life Communication, sponsored by University of California, San Francisco.
NCT01150968 is a NA study of End of Life Communication that has completed, run by University of California, San Francisco. The registered enrollment target is 166 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01150968, a NA study of End of Life Communication, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 166 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate whether the addition of teaching on communication at the end of life to the pre-existing resident curriculum will positively impact residents' knowledge and attitudes regarding communication at the end of life.
Primary Outcome
Residents participating in the intervention will demonstrate increased self-efficacy for end of life conversations.
Conditions Studied
Interventions
- BEHAVIORAL End of life education
Study Locations (1)
California
- UCSF Program in Medical Ethics - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2010-03 |
| Est. Completion | 2010-06 |
| Phase | NA |
What the finished NCT01150968 record still lists
NCT01150968 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 1 condition, with End of Life Communication appearing as the primary indexed condition, and to 1 intervention - of which End of life education is the first listed.
NCT01150968 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01150968 about?
NCT01150968 is a clinical study titled "An Educational Intervention to Improve Resident Comfort With Communication at the End of Life". The purpose of this study is to investigate whether the addition of teaching on communication at the end of life to the pre-existing resident curriculum will positively impact residents' knowledge and attitudes regarding communication at the end of life.
What is the current status of trial NCT01150968?
This trial is currently completed. It is a NA study. The enrollment target is 166 participants. The study started on 2010-03. Estimated completion is 2010-06.
What conditions does trial NCT01150968 study?
This clinical trial studies the following conditions: End of Life Communication.
What interventions are being tested in trial NCT01150968?
The interventions under investigation include: End of life education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01150968?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01150968 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01150968's enrollment target sits among peer trials
166 625th of 2000 higher than 1,375 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia